Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Board meeting intimation -26 May,2017-BSE
May 26, 2017
Board meeting intimation -26 May,2017-NSE
May 26, 2017
Intimation to BSE – May 26,2017
May 26, 2017
Intimation to NSE – May 26,2017
May 26, 2017
Intimation to BSE-May 24,2017
May 24, 2017
Intimation to NSE-May 24,2017
May 24, 2017
Intimation to BSE – April 18, 2017
April 18, 2017
Intimation to NSE – April 18, 2017
April 18, 2017
CG Report – Quarter ended – March 31, 2017 – BSE
March 31, 2017
CG Report – Quarter ended – March 31, 2017 – NSE
March 31, 2017
RECONCILIATION OF SHARE CAPITAL –QUARTER ENDED –MARCH 31,2017- BSE
March 31, 2017
RECONCILIATION OF SHARE CAPITAL –QUARTER ENDED –MARCH 31,2017-NSE
March 31, 2017
COMPLIANCE CERTIFICATE UNDER REGULATION 7(3) - BSE
March 31, 2017
COMPLIANCE CERTIFICATE UNDER REGULATION 7(3) – NSE
March 31, 2017
CERTIFICATE UNDER REGULATION 40(9)- HALF YEAR ENDED –MARCH 31,2017 –NSE
March 31, 2017
Audited Financial results for the year ended March 31,2017
March 31, 2017
Previous
1
...
Next
35 / 36